vimarsana.com
Home
Live Updates
NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS) : vimarsana.com
NeoImmuneTech to Partner with U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for Drug Development in Acute Radiation Syndrome (ARS)
/PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announced an agreement with the...
Related Keywords
Hiroshima ,
Japan ,
Alexandraa Wolfarth ,
Bennyj Chen ,
Sara Ferrando ,
Yujing Zou ,
Radiation Research Society ,
Benny Chen At Duke University ,
National Institute Of Allergy ,
Us National Institutes Of Health ,
Drug Administration ,
Prnewswire Neoimmunetech Inc ,
Neoimmunetech Inc ,
International Meeting ,
Chernobyl Nuclear Power Plant ,
Radiation Injury Treatment Network ,
National Institute ,
Infectious Diseases ,
Acute Radiation Syndrome ,
Chief Executive Officer ,
Benny Chen ,
Duke University ,
Injury Treatment Network ,
Annual Meeting ,
Radiation Syndrome ,
Yiqun Jiao ,
Byung Ha Lee ,
Presented August ,
Research Society ,
Annual International ,
Presented October ,
The Neoimmunetech ,
Nc ,
vimarsana.com © 2020. All Rights Reserved.